Market Research Report

A quick peek into the report

1.1   Overview
1.2   Impact Analysis
1.3   Market Drivers
1.3.1   Increase in Consumption and Production of Meat and Meat-Based Products
1.3.2   Supplanting Antibiotic Growth Promoters (AGPs) With Eubiotics
1.3.3   Rapid Increases in the Livestock Disease
1.4   Market Restraints
1.4.1   Complexity in Trading due to Stringent Government Policies
1.4.2   Lack of Sufficient Scientific Evidence
1.5   Market Opportunities
1.5.1   Rapid Investment to Enhance Animal Nutrition
1.5.2   Opportunity to Invest on Consumer Awareness Amid COVID-19

2.1   Key Strategies and Developments
2.1.1   Business Expansions and Contracts
2.1.2   New Product Launches and Development
2.1.3   Mergers and Acquisitions
2.1.4   Partnerships, Collaborations, and Joint Ventures
2.1.5   Others (Awards and Recognitions)
2.2   Competitive Benchmarking of Key Eubiotics Companies

3.1   Supply Chain Analysis
3.2   Market Trends in the Eubiotics Market
3.2.1   Shift Towards Natural Functional Ingredients
3.2.2   Brand Differentiation Through Innovative Packaging
3.2.3   Outbreak of Corona Pandemic Arising Immunity Concerns in Consumers
3.2.4   Shift of Animal Husbandry Towards Efficient and Targeted Investments
3.3   Impact of COVID-19 on Eubiotics Market
3.3.1   Consumer Perception
3.3.2   Government Regulation and Impact on Supply Chain
3.3.3   The Way Forward for the Nutrition and Supplement Industry
3.4   Patent Analysis
3.4.1   Patent Analysis (by Status)
3.4.2   Patent Analysis (by Applicant Profile)
3.4.3   Patent Analysis (by Product Type)
3.4.4   Patent Analysis (by Application)
3.5   Investment and Funding Landscape

4.1   Market Overview
4.2   Probiotics
4.2.1   Lactobacilli
4.2.2   Bifidobacterium
4.2.3   Streptococcus Thermophilus
4.2.4   Other Probiotics
4.3   Prebiotics
4.3.1   Inulin
4.3.2   Fructo-Oligosaccharides
4.3.3   Galacto-Oligosaccharides
4.3.4   Mannan-Oligosaccharides
4.4   Organic Acids
4.4.1   Formic Acid
4.4.2   Lactic Acid
4.4.3   Fumaric Acid
4.4.4   Propionic Acid
4.4.5   Others
4.5   Essential oils

5.1   Market Overview
5.2   Gut Health
5.3   Immunity
5.4   Yield Management
5.5   Others

6.1   Market Overview
6.2   Swine
6.3   Poultry
6.4   Ruminants
6.5   Aquaculture
6.6   Other Livestock

7.1   Market Overview
7.2   Solid or Dry Form
7.3   Liquid Form

8.1   Market Overview
8.2   Humans
8.3   Animals
8.3.1   Industrial Livestock
8.3.2   Domesticated Animals

9.1   Market Overview
9.2   Stand-up Pouches/Portion Control
9.3   Bulk Packaging
9.3.1   Packet Packaging
9.3.2   Bucket Packaging

10.1   Market Overview
10.2   North America
10.2.1   North America (by Offering Type)
10.2.2   North America Eubiotics Market (by Form)
10.2.3   North America Eubiotics Market (by End User)
10.2.4   North America Eubiotics Market (by Country)
10.2.4.1   U.S
10.2.4.2   Canada
10.2.4.3   Mexico
10.2.4.4   Rest-of-North America
10.3   South America
10.3.1   South America (by Offering Type)
10.3.2   South America (by Form)
10.3.3   South America (by End User)
10.3.4   South America Eubiotics Market (by Country)
10.3.4.1   Brazil
10.3.4.2   Argentina
10.3.4.3   Rest-of-South America
10.4   U.K.
10.4.1   U.K. Eubiotics Market (by Offering Type)
10.4.2   U.K. Eubiotics Market (by Form)
10.4.3   U.K. Eubiotics Market (by End User)
10.5   China
10.5.1   China Eubiotics Market (by Offering Type)
10.5.2   China Eubiotics Market (by Form)
10.5.3   China Eubiotics Market (by End User)
10.6   Europe
10.6.1   Europe Eubiotics Market (by Offering Type)
10.6.2   Europe Eubiotics Market (by Form)
10.6.3   Europe Eubiotics Market (by End User)
10.6.4   Europe Eubiotics Market (by Country)
10.6.4.1   Germany
10.6.4.2   France
10.6.4.3   Spain
10.6.4.4   Italy
10.6.4.5   Rest-of-Europe
10.7   Asia-Pacific & Japan
10.7.1   Asia-Pacific & Japan Eubiotics Market (by Offering Type)
10.7.2   Asia-Pacific & Japan Eubiotics Market (by Form)
10.7.3   Asia-Pacific & Japan Eubiotics Market (by End User)
10.7.4   Asia-Pacific & Japan Eubiotics Market (by Country)
10.7.4.1   Japan
10.7.4.2   India
10.7.4.3   Australia
10.7.4.4   South Korea
10.7.4.5   Rest-of-Asia-Pacific Japan
10.8   Middle East and Africa
10.8.1   Middle East and Africa Eubiotics Market (by Offering Type)
10.8.2   Middle East and Africa Eubiotics Market (by Form)
10.8.3   Middle East and Africa (by End User)
10.8.4   Middle East and Africa (by Country)
10.8.4.1   U.A.E
10.8.4.2   Saudi Arabia
10.8.4.3   South Africa
10.8.4.4   Rest-of-Middle East and Africa

11.1   Overview
11.2   Anpario plc.
11.2.1   Company Overview
11.2.2   Role of Anpario plc. in Global Eubiotics Market
11.2.3   Financials
11.2.4   SWOT ANALYSIS
11.3   Archer Daniels Midland
11.3.1   Company Overview
11.3.2   Role of Archer Daniels Midland in Global Eubiotics Market
11.3.3   Financials
11.3.4   SWOT ANALYSIS
11.4   BASF SE
11.4.1   Company Overview
11.4.2   Role of BASF SE in the Global Eubiotics Market
11.4.3   Financials
11.4.4   SWOT Analysis
11.5   BioGaia AB
11.5.1   Company Overview
11.5.2   Role of BioGaia AB in Global Eubiotics Market
11.5.3   Financials
11.5.4   SWOT ANALYSIS
11.6   Bluestar Adisseo Co
11.6.1   Company Overview
11.6.2   Role of Bluestar Adisseo Co in Global Eubiotics Market
11.6.3   Financials
11.6.4   SWOT ANALYSIS
11.7   Chr. Hansen Holding A/S
11.7.1   Company Overview
11.7.2   Role of Chr. Hansen Holding A/S in Global Eubiotics Market
11.7.3   Financials
11.7.4   SWOT ANALYSIS
11.8   DuPont de Nemours, Inc.
11.8.1   Company Overview
11.8.2   Role of DuPont de Nemours, Inc. in the Global Eubiotics Market
11.8.3   Financials
11.8.4   SWOT ANALYSIS
11.9   Koninklijke DSM N.V.
11.9.1   Company Overview
11.9.2   Role of Koninklijke DSM N.V. in Global Eubiotics Market
11.9.3   Financials
11.9.4   SWOT Analysis
11.10 Novozymes A/S
11.10.1   Company Overview
11.10.2   Role of Novozymes A/S in the Global Eubiotics Market
11.10.3   Financials
11.10.4   SWOT ANALYSIS
11.11   Yara International ASA
11.11.1   Company Overview
11.11.2   Role of Yara International ASA in Global Eubiotics Market
11.11.3   Financials
11.11.4   SWOT ANALYSIS
11.12   ADDCON GmbH
11.12.1   Company Overview
11.12.2   Role of ADDCON GmbH in Global Eubiotics Market
11.12.3   SWOT ANALYSIS
11.13   BEHN MEYER
11.13.1   Company Overview
11.13.2   Role of BEHN MEYER in the Global Eubiotics Market
11.13.3   SWOT ANALYSIS
11.14   BENEO GmbH
11.14.1   Company Overview
11.14.2   Role of BENEO GmbH in Global Eubiotics Market
11.14.3   SWOT ANALYSIS
11.15   Calpis Co., Ltd.
11.15.1   Company Overview
11.15.2   Role of Calpis Co., Ltd. in Global Eubiotics Market
11.15.3   SWOT ANALYSIS
11.16   Cargill, Inc.
11.16.1   Company Overview
11.16.2   Role of Cargill, Inc. in Global Eubiotics Market
11.16.3   SWOT Analysis
11.17   Kemin Industries, Inc.
11.17.1   Company Overview
11.17.2   Role of Kemin Industries, Inc. in Global Eubiotics Market
11.17.3   SWOT ANALYSIS
11.18   LALLEMAND Inc.
11.18.1   Company Overview
11.18.2   Role of LALLEMAND Inc. in Global Eubiotics Market
11.18.3   SWOT ANALYSIS
11.19   Lesaffre
11.19.1   Company Overview
11.19.2   Role of Lesaffre in the Global Eubiotics Market
11.19.3   SWOT ANALYSIS
11.2   MSPrebiotics Inc.
11.20.1   Company Overview
11.20.2   Role of MSPrebiotics Inc in Global Eubiotics Market
11.20.3   SWOT ANALYSIS
11.21   Neospark Drugs and Chemicals Private Limited
11.21.1   Company Overview
11.21.2   Role of Neospark Drugs and Chemical Private Limited in the Global Eubiotics Market
11.21.3   SWOT ANALYSIS
11.22   Novus International, Inc.
11.22.1   Company Overview
11.22.2   Role of Novus International, Inc. in Global Eubiotics Market
11.22.3   SWOT ANALYSIS
11.23   Roquette Freres
11.23.1   Company Overview
11.23.2   Role of Roquette Freres in the Global Eubiotics Market
11.23.3   SWOT ANALYSIS

12.1   Scope of the Report
12.2   Global Eubiotics Market Segmentation
12.3   Global Eubiotics Market Research Methodology
12.3.1   Assumptions
12.3.2   Limitations
12.3.3   Primary Data Sources
12.3.4   Secondary Data Sources
12.3.5   Data Triangulation
12.3.6   Market Estimation and Forecast

Table 1:   Impact Analysis of Market Drivers
Table 2:   Impact Analysis of Market Restraints
Table 1.1:   Major Livestock Diseases (by Type and Agro-Ecological Zone)
Table 2.1:   Competitive Benchmarking of Key Companies in Global Eubiotics Market
Table 4.1:   Global Eubiotics Market (by Offering Type), $Million, 2019-2025
Table 4.2:   Micro-Organisms Used as Probiotics in Animal Feed
Table 5.1:   Global Eubiotics Market (by Application), $Million, 2019-2025
Table 5.2:   Gut Health Products by Leading Companies
Table 5.3:   Immunity Products by Leading Companies
Table 5.4:   Yield Management Products by Leading Companies
Table 5.5:   Other Applications Products by Leading Companies
Table 6.1:   Global Eubiotics Market by Livestock, $Million, 2019-2025
Table 6.2:   Eubiotics Products for Swine by Key Companies
Table 6.4:   Eubiotics Products for Poultry by Key Companies
Table 6.5:   Eubiotics Products for Ruminants by Key Companies
Table 6.6:   Aquaculture Eubiotics Products by Key Companies
Table 6.7:   Eubiotics Products for Other Livestock by Key Companies
Table 7.1:   Global Eubiotics Market (by Form), $Million, 2019-2025
Table 8.1:   Global Eubiotics Market (by End User), $Million, 2019-2025
Table 9.1:   Global Eubiotics Market by Packaging Type, $Million, 2019-2025
Table 10.1:   Global Eubiotics Market (by Region), $Million, 2019-2025
Table 10.2:   North America Eubiotics Market (by Offering Type), $Million, 2019-2025
Table 10.3:   North America Eubiotics Market (by Form), $Million, 2019-2025
Table 10.4:   North America Eubiotics Market (by End User), $Million, 2019-2025
Table 10.5:   North America Eubiotics Market (by Country), $Million, 2019-2025
Table 10.6:   South America Eubiotics Market (by Offering Type), $Million, 2019-2025
Table 10.7:   South America Eubiotics Market (by Form), $Million, 2019-2025
Table 10.8:   South America Eubiotics Market (by End User), $Million, 2019-2025
Table 10.9:   South America Eubiotics Market (by Country), $Million, 2019-2025
Table 10.10:   U.K. Eubiotics Market (by Offering Type), $Million, 2019-2025
Table 10.11:   U.K. Eubiotics Market (by Form), $Million, 2019-2025
Table 10.12:   U.K. Eubiotics Market (by End User), $Million, 2019-2025
Table 10.13:   China Eubiotics Market (by Offering Type), $Million, 2019-2025
Table 10.14:   China Eubiotics Market (by Form), $Million, 2019-2025
Table 10.15:   China Eubiotics Market (by End User), $Million, 2019-2025
Table 10.16:   Europe Eubiotics Market (by Offering Type), $Million, 2019-2025
Table 10.17:   Europe Eubiotics Market (by Form), $Million, 2019-2025
Table 10.18:   Europe Eubiotics Market (by End User), $Million, 2019-2025
Table 10.19:   Europe Eubiotics Market (by Country), $Million, 2019-2025
Table 10.20:   Asia-Pacific & Japan Eubiotics Market (by Offering Type), $Million, 2019-2025
Table 10.21:   Asia-Pacific & Japan Eubiotics Market (by Form), $Million, 2019-2025
Table 10.22:   Asia-Pacific & Japan Eubiotics Market (by End User), $Million, 2019-2025
Table 10.23:   Asia-Pacific & Japan Eubiotics Market (by Country), $Million, 2019-2025
Table 10.24:   Middle East and Africa Eubiotics Market (by Offering Type), $Million, 2019-2025
Table 10.25:   Middle East and Africa Eubiotics Market (by Form), $Million, 2019-2025
Table 10.26:   Middle East and Africa Eubiotics Market (by End User), $Million, 2019-2025
Table 10.27:   Middle East and Africa Eubiotics Market (by Country), $Million, 2019-2025
Table 11.1:   Anpario plc.: Product Portfolio
Table 11.2:   Archer Daniels Midland Product Portfolio
Table 11.3:   BASF SE: Product Portfolio
Table 11.4:   BioGaia AB: Product Portfolio
Table 11.5:   Bluestar Adisseo Co: Product Portfolio
Table 11.6:   Chr. Hansen Holding A/S: Product Portfolio
Table 11.7:   DuPont de Nemours, Inc: Product Portfolio
Table 11.8:   Koninklijke DSM N.V. Product Portfolio
Table 11.9:   Novozymes A/S: Product Portfolio
Table 11.10:   Yara International ASA Product Portfolio
Table 11.11:   ADDCON GmbH: Product Portfolio
Table 11.12:   BEHN MEYER: Product Portfolio
Table 11.13:   BENEO GmbH Product Portfolio
Table 11.14:   Calpis Co., Ltd. Product Portfolio
Table 11.15:   Cargill, Inc.: Product Portfolio
Table 11.16:   Kemim Industries, Inc.: Product Portfolio
Table 11.17:   LALLEMAND Inc. Ltd.: Product Portfolio
Table 11.18:   Lesaffre Product Portfolio
Table 11.19:   MSPrebiotics Inc.: Product Portfolio
Table 11.20:   Neospark Drugs and Chemical Private Limited: Product Portfolio
Table 11.21:   Novus International, Inc.: Product Portfolio
Table 11.22:   Roquette Freres: Product Portfolio

Figure 1:   Macroeconomic Trends Impacting the Global Eubiotics Market
Figure 2:   Drivers and Restraints: Global Eubiotics Market
Figure 3:   Global Eubiotics Market Snapshot
Figure 4:   Global Eubiotics Market (by Offering Type), $Million, 2019 and 2025
Figure 5:   Global Eubiotics Market (by Application), $Million, 2019 and 2025
Figure 6:   Global Eubiotics Market (by Livestock Type), $Million, 2019 and 2025
Figure 7:   Global Eubiotics Market (by Form), $Million, 2019 and 2025
Figure 8:   Global Eubiotics Market (by End User), $Million, 2019 and 2025
Figure 9:   Global Eubiotics Market (by Packaging Type), $Million, 2019 and 2025
Figure 10:   Regional Eubiotics Market, 2019-2025
Figure 1.1:   Market Dynamics and Impact Analysis
Figure 1.2:   Per Capita Consumption of Livestock Product
Figure 2.1:   Strategies Adopted by the Key Players (January 2017-March 2020)
Figure 2.2:   Share of Key Market Strategies and Developments (January 2017-March 2020)
Figure 2.3:   Business Expansions and Contracts Share (by Company)
Figure 2.4:   Product Launches and Developments Share (by Company)
Figure 2.5:   Mergers and Acquisitions Share (by Company)
Figure 2.6:   Partnerships, Collaborations, and Joint Ventures Share (by Company)
Figure 3.1:   Supply Chain Analysis of the Global Eubiotics Market
Figure 3.2:   Advantages of Natural Functional Ingredients
Figure 3.3:   Benefits of Innovative Packaging
Figure 3.4:   Benefits of Customer Oriented Packaging
Figure 3.5:   Coronavirus in Livestock: Landscape
Figure 3.6:   Efficient and Targeted Investments by Governments of Various Countries to Promote Animal Husbandry
Figure 3.7:   Key Measure to Maintain Market Profitability
Figure 3.8:   Application-Wise Patents for Eubiotics, January 2017-April 2020
Figure 3.9:   Patent Analysis, (by Status), January 2017-April 2020
Figure 3.10:   Patent Analysis, (by Applicant Profile), January 2017-April 2020
Figure 3.11:   Patent Analysis (by Product Type), January 2017-April 2020
Figure 3.12:   Patent Analysis, (by Application), January 2017 to April 2020
Figure 3.13:   Investment and Funding in Global Eubiotics Market, January 2017-April 2020
Figure 3.14:   Investment and Funding Landscape Share (by Product Offering)
Figure 3.15:   Investment and Funding Landscape Share (by Round)
Figure 4.1:   Eubiotics Products and Ingredients (by Offering Type)
Figure 4.3:   Type of Probiotics in Eubiotics Market
Figure 4.4:   Effects of Lactobacilli as Probiotics
Figure 4.5:   Global Eubiotics Market (for Prebiotics), $Million, 2019-2025
Figure 4.6:   Types of Prebiotics Offerings
Figure 4.7:   Application of Inulin
Figure 4.8:   Application of Fructo-Oligosaccharides
Figure 4.9:   Properties of Galacto-Oligosaccharides
Figure 4.10:   Application of Organic Acids
Figure 4.11:   Global Eubiotics Market (for Organic Acids), $Million, 2019-2025
Figure 4.12:   Type of Organic Acids in Eubiotics Market
Figure 4.13:   Applications of Lactic Acid
Figure 4.14:   Global Eubiotics Market (for Essential Oils), $Million, 2019-2025
Figure 5.1:   Key Application of Eubiotics
Figure 5.2:   Global Eubiotics Market (for Gut Health), $Million, 2019-2025
Figure 5.3:   Global Eubiotics Market (for Immunity), $Million, 2019-2025
Figure 5.4:   Global Eubiotics Market (for Yield Management), $Million, 2019-2025
Figure 5.5:   Global Eubiotics Market (for Other Applications), $Million, 2019-2025
Figure 6.1:   Eubiotics Market by Livestock
Figure 6.2:   Application of Eubiotics for Swine
Figure 6.3:   Global Eubiotics Market (by Swine), $Million, 2019-2025
Figure 6.4:   Factors Limiting the Use of Alternative Traditional Feed Ingredients in Poultry Feed Formulation
Figure 6.5:   Application of Eubiotics for Poultry
Figure 6.6:   Global Eubiotics Market (for Poultry), $Million, 2019-2025
Figure 6.7:   Applications of Eubiotics for Ruminants
Figure 6.8:   Global Eubiotics Market (for Ruminants), $Million, 2019-2025
Figure 6.9:   Applications of Eubiotics for Aquaculture
Figure 6.10:   Global Eubiotics Market (for Aquaculture), $Million, 2019-2025
Figure 6.11:   Global Eubiotics Market (for Other Livestock), $Million, 2019-2025
Figure 7.1:   Eubiotics Products and Ingredients by Form
Figure 7.2:   Global Eubiotics Market (for Solid or Dry Form), $Million, 2019-2025
Figure 7.3:   Global Eubiotics Market (for Liquid Form), $Million, 2019-2025
Figure 8.1:   Global Eubiotics Market (by End User)
Figure 8.2:   Mechanistic Rationale for the Use of Eubiotics
Figure 8.3:   Global Eubiotics Market (for Humans), $Million, 2019-2025
Figure 8.4:   Global Eubiotics Market (for Animals), $Million, 2019-2025
Figure 8.5:   Livestock Production Index in Key Regions
Figure 8.6:   Advantage of Eubiotics for Domesticated Animals
Figure 9.1:   Eubiotics Market (by Packaging Type)
Figure 9.2:   Global Eubiotics Market (for Stand-up Pouches/Portion Control Packaging), $Million, 2019-2025
Figure 9.3:   Benefits of Bulk Packaging
Figure 9.4:   Global Eubiotics Market (for Bulk Packaging), $Million, 2019-2025
Figure 9.5:   Types of Bulk Packaging
Figure 10.1:   Global Eubiotics Market (by Region), Market Share and CAGR
Figure 10.2:   North America Eubiotics Market, $Million, 2019-2025
Figure 10.3:   North America Eubiotics Market (by Country), $Million, 2019-2025
Figure 10.4:   U.S Animal Feed Consumption in 2016
Figure 10.5:   The U.S. Eubiotics Market, $Million, 2019-2025
Figure 10.6:   Canada Livestock Production, 2010-2016
Figure 10.7:   Canada Eubiotics Market, $Million, 2019-2025
Figure 10.8:   Mexico Eubiotics Market, $Million, 2019-2025
Figure 10.9:   Rest-of-North America in the Eubiotics Market, $Million, 2019-2025
Figure 10.10:   South America Eubiotics Market, $Million, 2019-2025
Figure 10.11:   South America Eubiotics Market (by Country), $Million, 2019 and 2025
Figure 10.10:   Estimated Feed Consumption by Species
Figure 10.11:   Brazil Eubiotics Market, $Million, 2019-2025
Figure 10.12:   Argentina Eubiotics Market, $Million, 2019-2025
Figure 10.13:   Rest-of-South America Eubiotics Market, $Million, 2019-2025
Figure 10.14:   Livestock Production Index of the U.K.
Figure 10.15:   U.K. Eubiotics Market, $Million, 2019-2025
Figure 10.16:   Livestock Production Index of China
Figure 10.17:   China Eubiotics Market, $Million, 2019-2025
Figure 10.18:   EU Livestock Sector, Key Initiative Landscape
Figure 10.19:   Europe Eubiotics Market, $Million, 2019-2025
Figure 10.20:   Europe Eubiotics Market (by Country), $Million, 2019-2025
Figure 10.21:   Adoption Rate of Innovation by German Farmers, 2016 (%)
Figure 10.22:   Germany Eubiotics Market, $Million, 2019-2025
Figure 10.23:   France Eubiotics Market, $Million, 2019-2025
Figure 10.24:   Spain Eubiotics Market, $Million, 2019-2025
Figure 10.25:   Italy Eubiotics Market, $Million, 2019-2025
Figure 10.26:   Rest-of-Europe Eubiotics Market, $Million, 2019-2025
Figure 10.27:   Asia-Pacific & Japan Eubiotics Market, $Million, 2019-2025
Figure 10.28:   Asia-Pacific & Japan Eubiotics Market (by Country), $Million, 2019-2025
Figure 10.29:   Japan Eubiotics Market, $Million, 2019-2025
Figure 10.30:   Livestock Population In India (by Species), $Million
Figure 10.31:   India Eubiotics Market, $Million, 2019-2025
Figure 10.32:   Australia Eubiotics Market, $Million, 2019-2025
Figure 10.33:   South Korea Eubiotics Market, $Million, 2019-2025
Figure 10.34:   Rest-of-Asia-Pacific Japan Eubiotics Market, $Million, 2019-2025
Figure 10.35:   Middle East and Africa Eubiotics Market, $Million, 2019-2025
Figure 10.36:   Middle East and Africa Eubiotics Market (by Country), $Million, 2019 and 2025
Figure 10.37:   Number of Livestock by Type
Figure 10.38:   U.A.E Eubiotics Market, $Million, 2019-2025
Figure 10.39:   Saudi Arabia Eubiotics Market, $Million, 2019-2025
Figure 10.40:   South Africa Eubiotics Market, $Million, 2019-2025
Figure 10.41:   Rest-of-Middle East and Africa Eubiotics Market, $Million, 2019-2025
Figure 11.1:   Share of Key Companies
Figure 11.2:   Anpario plc.: Overall Financials, 2016-2018
Figure 11.3:   Anpario plc.: Net Revenue by Regional Segment, 2016-2018
Figure 11.4:   Anpario plc.: SWOT Analysis
Figure 11.5:   Archer Daniels Midland: Overall Financials, 2017-2019
Figure 11.6:   Archer Daniels Midland: Net Revenue by Business Segment, 2017-2019
Figure 11.7:   Archer Daniels Midland: Net Revenue by Regional Segment, 2016-2018
Figure 11.8:   Archer Daniels Midland: SWOT ANALYSIS
Figure 11.9:   BASF SE: Overall Financials, 2017-2019
Figure 11.10:   BASF SE: Net Revenue by Business Segment, 2017-2019
Figure 11.11:   BASF SE: Net Revenue by Regional Segment, 2017-2019
Figure 11.12:   BASF SE: SWOT Analysis
Figure 11.13:   BioGaia AB: Overall Financials, 2017-2019
Figure 11.14:   BioGaia: Net Revenue by Business Segment, 2016-2018
Figure 11.15:   BioGaia AB: Net Revenue by Regional Segment, 2017-2019
Figure 11.16:   BioGaia AB: SWOT Analysis
Figure 11.17:   Bluestar Adisseo Co: Overall Financials
Figure 11.18:   Bluestar Adisseo Co: Net Revenue by Regional Segment, 2017-2019
Figure 11.19:   Bluestar Adisseo Co: SWOT Analysis
Figure 11.20:   Chr. Hansen Holding A/S: Overall Financials, 2017-2019
Figure 11.21:   Chr. Hansen Holding A/S: Net Revenue by Business Segment, 2017-2019
Figure 11.22:   Chr. Hansen Holding A/S: Net Revenue by Regional Segment, 2017-2019
Figure 11.23:   Chr. Hansen Holding A/s: SWOT ANALYSIS
Figure 11.24:   DuPont de Nemours, Inc.: Overall Financials, 2017-2019
Figure 11.25:   DuPont de Nemours, Inc.: Net Revenue by Business Segment, 2017-2019
Figure 11.26:   Net Revenue by Regional Segment, 2017-2019
Figure 11.27:   DuPont de Nemours, Inc: SWOT ANALYSIS
Figure 11.28:   Koninklijke DSM N.V.: Overall Financials, 2017-2019
Figure 11.29:   Koninklijke DSM N.V. Net Sales by Business Segment, 2017-2019
Figure 11.30:   Koninklijke DSM N.V.: Net Sales by Regional Segment, 2017-2019
Figure 11.31:   Koninklijke DSM N.V SWOT Analysis
Figure 11.32:   Novozymes A/S: Overall Financials, 2016-2018
Figure 11.33:   Novozymes A/S: Net Revenue by Business Segment, 2017-2019
Figure 11.34:   Novozymes A/S: Net Revenue by Regional Segment, 2016-2018
Figure 11.35:   Novozymes A/S: SWOT Analysis
Figure 11.36:   Yara International ASA: Overall Financials, 2017-2019
Figure 11.37:   Yara International ASA: Net Revenue by Business Segment, 2018 and 2019
Figure 11.38:   Yara International: Net Revenue by Regional Segment, 2017-2019
Figure 11.39:   Yara International ASA: SWOT ANALYSIS
Figure 11.40:   ADDCON GmbH: SWOT Analysis
Figure 11.41:   BEHN MEYER: SWOT Analysis
Figure 11.42:   BENEO GmbH: SWOT Analysis
Figure 11.43:   Calpis Co., Ltd.: SWOT Analysis
Figure 11.44:   Cargill, Inc.: SWOT Analysis
Figure 11.45:   Kemim Industries, Inc.: SWOT ANALYSIS
Figure 11.46:   Lallemand Inc.: SWOT Analysis
Figure 11.47:   Lesaffre: SWOT Analysis
Figure 11.48:   MSPrebiotics Inc.: SWOT ANALYSIS
Figure 11.49:   Neospark Drugs and Chemical Private Limited: SWOT Analysis
Figure 11.50:   Novus International Inc, Swot Analysis
Figure 11.51:   Roquette Freres: SWOT Analysis
Figure 12.1:   Eubiotics Market Scope
Figure 12.2:   Global Eubiotics Market Segmentation
Figure 12.3:   Report Methodology
Figure 12.4:   Primary Interviews Breakdown, by Player, Designation, and Region
Figure 12.5:   Data Triangulation
Figure 12.6:   Top Down and Bottom-Up Approaches for Market Estimation

Report Description

Market Report Coverage - Global Eubiotics Market
Base Year	2019	Market Size	$5.24 Billion
Forecast Period	2020-2025	Value Projection and Estimation by 2025	$7.74 Billion
CAGR During Forecast Period	7.06%	Number of Tables	69
Number of Pages	304	Number of Figures	176
Research Hours	940
Market Segmentation	• Offering Type– Probiotics (Lactobacilli, Bifidobacterial, Streptococcus Thermophilus, Others), Prebiotics(Fructo-Oligosaccharides, Galacto-Oligosaccharides, and Mannan-Oligosaccharide), Organic Acids (Formic Acid, Lactic Acid, Fumaric Acid, Propionic Acid, and Acetic Acid) and Essential Oils • Application – Gut Health, Immunity, Yield and Others • Livestock Type – Swine, Poultry, Ruminants, Aquaculture, and Others • Form – Liquid and Solid form/Dry Form •End User – Humans and Animals (Industrial Livestock and Domesticated animals) • Packaging Type – Stand-up Pouches/ Portion Control and Bulk Packaging (Packet Packaging and Bucket Packaging)
Regional Segmentation	• North America – U.S., Canada, Mexico, and Rest-of-North America • South America- Brazil, Argentina, and Rest-of-South America • Europe – Germany, France, Italy, Spain, and Rest-of-Europe • U.K • China • Asia-Pacific&Japan – Japan, Australia, India, South Koreaand Rest-of-Asia-Pacific • Middle East & Africa – U.A.E, South Africa, Saudi Arabia and Rest-of-Middle East & Africa
Growth Drivers	• Increase in consumption and production of meat and meat-based products • Supplanting antibiotic growth promoters (AGPs) with eubiotics • Rapid increases in the livestock disease
Market Challenges	• Complexity in trading due to stringent government policies • Lack of sufficient scientific evidence • Impact of COVID-19 on supply chain
Market Opportunities	• Rapid investment in animal nutrition • Opportunity to invest on consumer awareness amid COVID-19
Key Eubiotics Companies Profiled	• Public Players: Anpario plc, Archer Daniels Midland, BASF SE, BioGaia AB, Bluestar Adisseo Co, Chr. Hansen Holding A/S, DuPont de Nemours, Inc., Koninklijke DSM N.V., Novozymes A/S, and Yara International ASA • Private Players: ADDCON GmbH, BEHN MEYER, BENEO GmbH, Calpis Co., Ltd., Cargill, Inc., Kemin Industries, Inc., LLEMAND Inc., Lesaffre, MSPrebiotics Inc., Neospark Drugs and Chemicals Private Limited, Novus International, Inc, and Roquette Freres

Key Questions Answered in this Report:

•   What is the estimated global eubiotics market size in terms of value during the period 2019-2025?
•   What is the expected future scenario and revenue to be generated by different types of eubiotics offerings, including probiotics, prebiotics, organic acid, and essential oils?
•   What is the expected future scenario and revenue to be generated by the application segments for eubiotics, including gut health, immunity, and yield, among others?
•   What is the expected future scenario and revenue to be generated by eubiotics in different types of forms, including solid or dry and liquid?
•   What is the expected future scenario and revenue to be generated by eubiotics in different livestock types, including poultry, pig, ruminants, and aquaculture, among others?
•   What is the expected future scenario and revenue to be generated by eubiotics in different end-user types, including humans and animals?
•   What is the expected future scenario and revenue to be generated by eubiotics in different packaging types, including stand-up pouches/portion control and bulk packaging?
•   What is the competitive strength of the key players in the eubiotics market on the basis of the analysis of their recent developments, product offerings, and regional presence?
•   What are the emerging trends in the global eubiotics market?
•   What is the funding and investment landscape in the global eubiotics market?
•   What are the dynamics of the global eubiotics market including market drivers, restraints, and opportunities?
•   What is the SWOT analysis for leading companies in the eubiotics market?

Market Overview

Market Size, Forecast, and Analysis

The market report includes several drivers that are influencing the changing demand for and dynamics of the eubiotics industry. The eubiotics market has undergone significant and dynamic changes in the past five years, specifically with the introduction of new and advanced solutions to improve animal health and well-being. With the increase in the world population leading to a rise in the global demand for meat food and the global prohibition on the usage of antibiotics growth promoters, livestock growers are increasingly adopting eubiotics products and ingredients to increase the yield and productivity of animals. The utilization of eubiotics as an animal feed has resulted in promoting the growth and maintaining animal health by managing the gut health and reduction in the proliferation of the undesirable pathogenic bacteria. As a result, the eubiotics market is anticipated to progress due to the ever-growing affinity for more convenient animal feed solutions than the traditional methods.

Eubiotics market encompasses a wide array of offerings,including probiotics, prebiotics, organic acids, and essential oils. The probiotics offering type comprises a board range of bacterial strain including Lactobacilli, Bifidobacteria, Streptococcus Thermophilus, and others. Prebiotics offering type consists of Fructo-Oligosaccharides, Galacto-Oligosaccharides, and Mannan-Oligosaccharide that are offered by different companies present in the market. The organic acids section of the offering type consists of formic acid, lactic acid, fumaric acid propionic acid, and acetic acid. These offerings have applications in the management of gut health, immunity, and yield, among others.

The presence of these probiotics, prebiotics, organic acids, and essential oils in the market has led to an exponential growth of the eubiotics market.

Figure 3: Global Eubiotics Market Snapshot

Source: Expert Interviews and BIS Research Analysis

The eubiotics market is projected to grow from $5.24 billion in 2019 to $7.74 billion by 2025, growing at a CAGR of 7.06% from 2019 to 2025. High growth in the market is expected to be driven by the increasing consumption and demand for meat, growing livestock diseases, and ban on the utilization of antibiotics growth promoters. Governments of developed as wellas developing countries have also taken several initiatives to promote eubiotics, especially after the ban on antibodies growth promoters. Moreover, the increasing demand for and consumption of the meat and meat-based products is also expected to drive the market in the future.

Competitive Landscape

The exponential utilization of advanced solutions in the eubiotics market has created opportunities for companies to adopt strategies such as collaborations, joint ventures, product launches, and developments and partnerships.

The established companies in the eubiotics market are focusing more on business expansions and on finding ways to improve the existing techniques. Moreover, product launch activities have increased in the market during the last three years. Presently, the big four eubiotics companies, namely Chr. Hansen Holding A/S, Koninklijke DSM N.V., Kemin Industries, Inc., and BASF, are constantly increasing their investment in animal health improvement, by acquiring or collaborating with other companies.

Several other companies, such as Anpario plc., Novus International Inc., Lallemand, Inc, and LESAFFRE, have launched different products to compete with the market-dominant players. The wide-spread adoption of advanced feed solutions is essential for linking the gap to improve animal health effectively.